GetTopicDetailResponse(id=b862142402d, topicName=PI3K/AKT/mTOR, introduction=PI3K/AKT/mTOR, content=null, image=null, comments=4, allHits=432, url=https://h5.medsci.cn/topic?id=14240, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=103352, tagList=[TagDto(tagId=103352, tagName=PI3K/AKT/mTOR)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=1789034, encodeId=858f1e89034bf, content=<a href='/topic/show?id=b862142402d' target=_blank style='color:#2F92EE;'>#PI3K/AKT/mTOR#</a>, objectTitle=Br J Pharmacol:丁酸鹽通過增強腸道屏障功能和FFA2介導的PI3K/AKT/mTOR信號通路改善糖尿病腎病骨骼肌萎縮, objectType=article, longId=218682, objectId=875c218682b2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=875c218682b2, replyNumber=0, likeNumber=60, createdTime=2022-08-16, rootId=0, userName=liuli5079, userId=7931272, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=875c218682b2, moduleTitle=Br J Pharmacol:丁酸鹽通過增強腸道屏障功能和FFA2介導的PI3K/AKT/mTOR信號通路改善糖尿病腎病骨骼肌萎縮, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=875c218682b2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1789033, encodeId=50dd1e890337e, content=<a href='/topic/show?id=b862142402d' target=_blank style='color:#2F92EE;'>#PI3K/AKT/mTOR#</a>, objectTitle=Cell Death Dis:E2F1介導DDX11轉(zhuǎn)錄激活通過PI3K/AKT/mTOR通路促進肝細胞癌發(fā)生發(fā)展, objectType=article, longId=194080, objectId=4ff6194080ed, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4ff6194080ed, replyNumber=0, likeNumber=61, createdTime=2021-01-26, rootId=0, userName=liuli5079, userId=7931272, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4ff6194080ed, moduleTitle=Cell Death Dis:E2F1介導DDX11轉(zhuǎn)錄激活通過PI3K/AKT/mTOR通路促進肝細胞癌發(fā)生發(fā)展, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=4ff6194080ed)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1789031, encodeId=31111e890316d, content=<a href='/topic/show?id=b862142402d' target=_blank style='color:#2F92EE;'>#PI3K/AKT/mTOR#</a>, objectTitle=Mol Med Rep:TGF-β1通過PI3K/AKT/mTOR/S6K1信號通路促進人成骨細胞的成骨分化, objectType=article, longId=162772, objectId=f952162e72ec, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f952162e72ec, replyNumber=0, likeNumber=94, createdTime=2019-12-11, rootId=0, userName=liuli5079, userId=7931272, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f952162e72ec, moduleTitle=Mol Med Rep:TGF-β1通過PI3K/AKT/mTOR/S6K1信號通路促進人成骨細胞的成骨分化, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=f952162e72ec)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1789032, encodeId=eaaa1e89032eb, content=<a href='/topic/show?id=b862142402d' target=_blank style='color:#2F92EE;'>#PI3K/AKT/mTOR#</a>, objectTitle=BMC Anesthesiol:右美托咪定通過激活PI3K/AKT/MTOR途徑抑制七氟醚麻醉誘導的神經(jīng)炎癥反應(yīng), objectType=article, longId=178200, objectId=6b031e8200a9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6b031e8200a9, replyNumber=0, likeNumber=76, createdTime=2019-11-17, rootId=0, userName=liuli5079, userId=7931272, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6b031e8200a9, moduleTitle=BMC Anesthesiol:右美托咪定通過激活PI3K/AKT/MTOR途徑抑制七氟醚麻醉誘導的神經(jīng)炎癥反應(yīng), moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=6b031e8200a9)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話題小助手
2020-05-29